ORMP - ORAMED PHARMACEUTICALS INC.
3.62
0.240 6.630%
Share volume: 163,978
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.38
0.24
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-27-2025 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 203.652 M | 184.223 M | 165.081 M | 155.278 M | 147.539 M | 161.684 M | 220.493 M | |
| Current Assets | 177.095 M | 153.270 M | 142.774 M | 143.221 M | 131.476 M | 99.026 M | 136.117 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 80.285 M | 1.778 M | 42.741 M | 55.281 M | 26.701 M | 22.865 M | 4.038 M | |
| Short Term Investments | 77.733 M | 66.206 M | 57.455 M | 32.229 M | 29.427 M | 59.278 M | 78.470 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 18.576 M | 84.753 M | 42.104 M | 54.420 M | 74.516 M | 15.797 M | 52.179 M | |
| Total Non-current Assets | 25.094 M | 2.345 M | 21.071 M | 10.911 M | 9.530 M | 44.298 M | 76.213 M | |
| Property Plant Equipment | 819.000 K | 765.000 K | 718.000 K | 698.000 K | 671.000 K | 645.000 K | 614.000 K | |
| Other Assets | 25.738 M | 30.188 M | 21.589 M | 11.359 M | 15.392 M | 62.013 M | 83.762 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 203.652 M | 184.223 M | 165.081 M | 155.278 M | 147.539 M | 161.684 M | 220.493 M | |
| Total liabilities | 37.931 M | 8.069 M | 9.559 M | 9.931 M | 7.645 M | 8.101 M | 18.163 M | |
| Total current liabilities | 33.556 M | 3.733 M | 5.273 M | 5.685 M | 5.492 M | 3.693 M | 6.119 M | |
| Accounts Payable | 1.267 M | 3.483 M | 4.995 M | 5.140 M | 5.275 M | 2.159 M | 4.861 M | |
| Other liabilities | 346.000 K | 307.000 K | 257.000 K | 216.000 K | 120.000 K | 648.000 K | 589.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 346.000 K | 307.000 K | 257.000 K | 216.000 K | 120.000 K | 648.000 K | 589.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 166.639 M | 177.065 M | 156.441 M | 146.265 M | 140.812 M | 154.529 M | 203.282 M | |
| Common stock | 322.659 M | 323.873 M | 322.868 M | 322.881 M | 325.070 M | 325.499 M | 325.857 M | |
| Retained earnings | -156.020 M | -146.808 M | -166.427 M | -176.616 M | -184.258 M | -170.970 M | -122.575 M |